Advertisement

Topics

CVS 2018 Formulary: Outcomes-Based Contracts In Oncology, Obesity, COPD

17:36 EDT 2 Aug 2017 | SCRIP

And for diabetes, Jardiance is out and Invokana is in; CVS formulary update includes far fewer exclusions than previous years...

      

Related Stories

 

Original Article: CVS 2018 Formulary: Outcomes-Based Contracts In Oncology, Obesity, COPD

NEXT ARTICLE

More From BioPortfolio on "CVS 2018 Formulary: Outcomes-Based Contracts In Oncology, Obesity, COPD"

Quick Search
Advertisement
 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...